Scientific Symposia in Frontline Areas of Research

The 20th Annual Symposium of the Foundation on the topic “Regenerative Medicine – Current and Future Perspectives” was held on March 22, 2014 at the National Institute of Immunology, New Delhi. The symposium was jointly organized with Institute of Liver and Biliary Sciences (ILBS), New Delhi. The Chief Guest, Dr. R. Chidambaram, Principal Scientific Adviser to the Government of India delivered the inaugural address followed by the key note address by Prof. Pierre Alain Clavien. Eminent scientists from India and abroad participated in the symposium and deliberated on the recent advances in regenerative medicine and stem cell therapy and its recent applications in various disease areas such as kidney disorders, type II diabetes mellitus, neuronal disorder, ocular disorders, liver injury, cardiac disorders etc.
The symposium was attended by over 230 delegates from all over India.

The Foundation conducted its 19th Annual Symposium on the topic “Gains of Genomic Research in Biology and Medicine” on February 4, 2013 at the National Institute of Immunology, New Delhi under the convenership of Prof. N.K. Mehra, Head, Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi. The symposium was co-sponsored by Immunology Foundation.

Prof. Dhavendra Kumar, Consultant in Clinical Genetics, Institute of Molecular and Experimental Medicine, University Hospital of Wales, Cardiff, UK was the Chief Guest and Key-note speaker at the symposium. A special lecture on “Generic Drugs to Genomic Medicines” was delivered by Prof. Samir K. Brahmachari, Director General, Council of Scientific and Industrial Research, Government of India. The other prominent speakers were Prof. I.C. Verma, Sir Ganga Ram Hospital, Dr. Bert de Vries from University of Nijmegan, Netherlands, Dr. GPS Raghava, IMTECH, Chandigarh, Dr. Rajiv Sarin, The Advanced Centre for Treatment, Research and Education in Cancer, Mumbai Dr. Seyed Hasnain, Indian Institute of Technology, New Delhi etc. The symposium addressed various issues like Genome to Genetic medicine : Opportunities and Challenges, Genetic Council in the Genomic Era, Genetic and Genomic Tools in Clinical Diagnosis, Genomic Architecture of HIV Infection, in silico Design of Subunit Vaccines, Genetics of Breast Cancer in Indian Population, Genetic Variations and its Implications in Health and Diseases etc.

This symposium received a good response from the scientific community including young researchers, students and it was attended by as many as 270 delegates all over India.

Ranbaxy Science Foundation conducted its 18^th Annual Symposium on the topic “Ageing Gracefully” on February 27, 2012 at the Jawaharlal Nehru Auditorium, All India Institute of Medical Sciences, New Delhi in association with International Congress on Gerontology & Geriatric Medicine. The Co-Organizers of the symposium were All India Institute of Medical Sciences and University College of Medical Sciences, New Delhi.

Prof. Finbarr Martin, President, British Geriatrics Society, London was the Chief Guest and Key-note of the Symposium. The other three renowned international speakers in the symposium were Prof. Yasumichi Arai, Keio University School of Medicine, Japan, Prof. John Morley, Saint Louis University School of Medicine, USA and Prof. Peter Crome, Keele University, UK

The program of the symposium was well designed and experts from major research institutions were invited to deliver the lectures. The symposium addressed various topics like Human Longevity Research, Alzheimer’s Disease, Frailty - Joining the Geriatric Giants, Demographics of Ageing, Functional disability and its gender dimensions, Health Issues in Old Age, Vitamin D: skeletal and extra skeletal implications, Challenges of vascular diseases in ageing population, Civil society and policy formulation, National Program for Health Care of the Elderly etc.  This symposium was attended by as many as 300 delegates all over India.

The XVII Annual Symposium on “New Frontiers in Drug Design, Discovery and Development” was conducted on February 11, 2011 at the National Institute of Immunology, New Delhi.

Dr. Hiroyuki Koike, Corporate Fellow-R&D Division, Daiichi Sankyo Co., Japan was the Chief Guest and Key-note Speaker of the symposium. The topic of Dr. Koike’s Key-note Address was “Innovations in Design and Discovery of New Drugs for Cardiovascular Disorders: Special Focus on the Drugs that Inhibit the Renin-Angiotensin System”.

The symposium focused on various topics in Drug Design, Discovery and Developemnt such as New approaches to Molecular modeling, Novel Peptido-mimetics, Approaches towards the development of chimeric DPPA/ACE inhibitor for treating metabolic syndrome, importance of chemical and biological space complementarity in drug discovery, improving R&D productivity through external innovation, new approaches to the development of antibacterial agents with special reference to quinolone, discovery of new anti-TB agents, discovery of novel anti-malarial drugs, integration between drug discovery and development, meeting the challenges of microbial resistances in infectious diseases, interface between traditional systems drugs and modern drug discovery and re-positioning of discovered drugs.

The symposium was attended by over 230 scientists and medical students across India.

The first Symposium in this series, entitled "Molecular Genetics and Gene Therapy: The New Frontier" was held on September 12, 1994 in New Delhi. The symposium was meant to review the scientific progress made in gene therapy for haemoglobinopathies, oral cancer and a wide range of hereditary conditions, particularly prevalent in India. Sir David Weatherall, FRS, Regius Professor of Medicine, University of Oxford, Oxford, UK, was the Chief Guest and delivered the key-note address entitled "The New Genetics and Clinical Practice". Six eminent Indian Scientists, engaged in research in the areas of molecular genetics and gene therapy, presented their work. Nearly a hundred invited scientists many of them young scientists, from Universities, Medical Institutions and National Research Laboratories attended this symposium.

Despite the health, epidemiological and demographic transitions that are taking place in the developing world, bringing chronic degenerative diseases such as cardiovascular disease, cancer etc. into greater prominence, infectious diseases still constitute the leading cause of mortality and morbidity in the world as a whole and in developing countries in particular. There is a restless tide of infectious diseases. The Second Annual Symposium, therefore, focused on the role of molecular biology and molecular genetics in mankind's struggle against infectious diseases and hence entitled as "Microbial Threats to Health in 21st Century". The Symposium was held on January 22, 1996 at the National Institute of Immunology, New Delhi. Eighteen eminent scientists, engaged in research in this area presented their work. The Chief Guest, Prof. Myron E. Essex, Chairman, Harvard AIDS Institute and the Department of Cancer Biology, The Harvard Institute of Public Health, USA, delivered the key note address entitled "The AIDS Virus: A Continuing Challenge". Two hundred and fifty scientists attended this Symposium. The proceedings of this symposium were published and formally released for distribution by Dr. Charles R. Scriver, Professor of Paediatrics and Human Genetics, McGill University, Montreal, Canada, at a special function organized in New Delhi, on December 3, 1996.

The Third Annual Symposium entitled "Molecular Genetic Approaches to Vaccination" was held on January 21, 1997 at the National Institute of Immunology, New Delhi. The aim of the symposium was to address insurgence problems of infectious diseases like Cholera, Malaria, Hepatitis, Diarrhoea and certain non-infectious diseases like Cancer, Human and animal fertility through effective vaccines using molecular genetic approaches. Sixteen eminent scientists engaged in research in this area presented their work. The Chief Guest, Prof. Sir Gustav J Nossal, Ex. Director, Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Australia and Chairman, Global Vaccination Programme of the World Health Organization delivered the Key-note address entitled "Vaccines 200 years After Jenner: The Promise and the Perils". This symposium was attended by over 250 invited scientists from all over the country.

The Fourth Annual Symposium entitled "Drug Resistance: Mechanisms and Management" was held on November 13, 1997 at the National Institute of Immunology, New Delhi. The objective of the symposium was to bring together basic and clinical scientists to discuss the rising problems of multi drug resistance of microbes and tumours - an increasingly global phenomenon, their impact on treatment and deliberate on resurgence of infectious diseases like Malaria and Tuberculosis. Thirteen eminent scientists engaged in research in this area presented their work at this symposium. The Chief Guest Prof. Joshua Lederberg, Nobel Laureate, University Professor, Rockefeller University, New York, delivered the key-note address "Genomic Plasticity and Bacterial Adaptation to Adverse Agents". It was attended by over 260 scientists from all over the country.

The Fifth Annual Symposium entitled "Molecular Intervention in Disease" was held on October 31, 1998 at the National Institute of Immunology, New Delhi under the Chairmanship of Prof. V. Ramalingaswami, FRS, National Research Professor, All India Institute of Medical Sciences, New Delhi. Prof. Inder M. Verma, Professor of Molecular Biology, The Salk Institute for Biological Studies, San Diego, California, USA, was the Chief Guest. He also delivered a keynote address "Gene Therapy : Trials and Tribulations". Fifteen eminent scientists presented their research work in the symposium. This symposium was well attended by over 270 scientists from all over the country.

The Sixth Annual Symposium entitled "Recent Developments in the Management of Cancer of Uterine Cervix" was held on December 11, 1999 at the National Institute of Immunology, New Delhi. The aim of the symposium was to address this widely prevalent and rising cancer problem amongst the women worldwide. Prof. N.K. Ganguly, Director General, Indian Council of Medical Research, New Delhi, was the Chief Guest. Fourteen eminent scientists deliberated on the topic. It was attended by over 150 scientists.

The Seventh Annual Symposium entitled "The Metabolic Syndrome" was held on December 23, 2000 at the All India Institute of medical Sciences, New Delhi.Dr. Steven M. Haffner, Professor, Department of Medicine and Division of Clinical Epidemiology, University of Texas Health Sciences Center at San Antonio, USA, was the Chief Guest and Key note speaker. Thirteen eminent scientists were invited to deliberate on the topic. The symposium was attended by over 260 scientists.

The Eighth Annual Symposium of Ranbaxy Science Foundation on Advances in Hematopoietic Stem Cell Transplantation was organized at National Institute of Immunology, New Delhi on February 18, 2002 to discuss the factors that influence the success of a bone marrow transplantation and recent developments in the area. Prof. Mammen Chandy, Prof. of Medicine & Head, Department of Haematology,Christian Medical College Hospital, Vellore;Fellow of the Royal Australasian College of Physicians as well as Fellow of the Royal College of Pathologists of Australasia; delivered the keynote address on “Hematopoietic Stem Cell Transplantation: Current Status and Future Directions ". Prof Chandy is well known for his work in the area of Stem Cell Transplantation. The Symposium, coordinated by Prof. N.K. Mehra, Head, Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, was addressed by several experts from various centres across India. The Symposium highlighted the importance of stem cells in cancer cure, epidemiology of hematological cancers in India, molecular targets for their management, underlying immune mechanisms, cord blood transplantation, donor marrow registries, post transplant monitoring etc. Twelve eminent scientists were invited to deliberate on the topic. The symposium was attended by over 200 scientists.

The IX Annual symposium of Ranbaxy Science Foundation, co-sponsored by Immunology Foundation of India was held on Jan 03, 2003 at the India Habitat Centre, New Delhi. The theme for this year's symposium is "Therapeutic Antibodies", the advent of which has revolutionized the treatment modalities for therapy of various chronic and morbid diseases like Rheumatoid Arthritis & Cancer. The symposium was organized by Dr. O.P.Sood of Ranbaxy Science Foundation. The scientific program of the symposium was moderated by Prof. G.P. Talwar, of Talwar Research Foundation.

Antibodies are mixture of closely related immune system proteins which are produced in the blood to recognize and bind to foreign invaders, singling them out for elimination by body's defense mechanism. Monoclonal antibodies (mAbs) are antibodies produced by a single white blood cell, making them specific and selective tools for therapeutic development. In other words, mAbs are analogous to guided missiles, always homing in on a specific target.

The keynote address in this years symposium" Bench to bedside : Anti TNF. A paradigm for biological targeted therapy" has been delivered by Prof. Ravinder N Maini, Head, Kennedy Institute of Rheumatology Division, Imperial College of Science, Technology and Medicine, London. Prof. Maini was awarded the prestigious Craford prize (Royal Swedish Academy of Sciences) along with Prof. Marc Feldmann for their groundbreaking work in developing new therapies for the treatment of Rheumatoid Arthritis. Prof. Maini has been the pioneer in identification of TNF blockade as an effective therapeutic principle in Rheumatoid Arthritis.

The symposium was also addressed by pioneer scientists from abroad including Prof. T.K.S. Mukkur (Australia) and Prof. Rainer Fischer (Germany) covering a wide range of topics from the use of antibodies in Inflammation, Infectious diseases and their production. Renowned scientists from India including Prof. G.P Talwar, Dr.Satish Gupta, Prof. Ashok Kumar, Prof. Ramnath Misra, Dr. A.N. Malviya, Dr. Soniya Nityanand, Dr. Ashok Seth, Dr. Ramesh Nimmagadda, Prof. Lalit Kumar, Dr. Anant Kumar, Dr. Rajan Sriraman, Prof. PV Subbarao, Dr. Koninika Ray, Dr. Subrata Sinha and Dr. Usha Sarma talked about the management of diseases like Cancer, Aplastic Anaemia, Transplant related diseases, fertility control, Inflammation and Allergies using therapeutic antibodies. The symposium was well attended by over 225 scientists from all over India.

The X Annual symposium of Ranbaxy Science Foundation on "Non-alcoholic Fatty Liver Disease" was held on March 1-2, 2004 at the Maulana Azad Medical College, New Delhi. Dr. Arun J. Sanyal, Professor of Medicine and Chairman, Division of Gastroenterology, Hepatology and Nutrition, Medical College of Virginia, USA was the chief guest and key note speaker. A galaxy of eminent doctors and scientists from India and abroad which included basic scientists, pathologists, clinicians, epidemiologists, radiologists, endocrinologists and public health experts deliberated on various issues related to NAFLD during the series of scientific sessions of the symposium. A total of about 150 delegates participated in the conference. Dr. S.K. Sarin, Professor and Head, Gastroenterology, G.B. Pant Hospital, New Delhi who was the moderator of the programme delivered the frontline messages related to 'NAFLD' especially on the understanding of the mechanisms leading to fatty liver disease and its relation to insulin resistance etc. The programme concluded with a valedictory address by Prof. J.S. Bajaj, Former Head, Endocrinology, AIIMS, New Delhi.

The 11th Annual Symposium of Ranbaxy Science Foundation on "Stem Cell Research : From Bench to Bedside" was held at the L.V. Prasad Eye Institute, Hyderabad on March 5, 2005. Eminent doctors from all over India and abroad working in the area of stem cell research were invited to deliberate on their research work. The purpose of the symposium on this hot topic was to get together some of the leading stem cell researchers of the country to review the present status of research in this field in the country. The main topics covered in the symposium included Stem Cell technology in ophthalmology, the whys and hows of stem cell research in India, Asrij, a Novel Marker for ES Cells, Understanding the Mechanisms of Carcinogenesis using Cancer Stem Cells as a Model System, Investigation of early Cardiomyogenesis and Neutogenesis using ES Cell Model, Arrest, Release and Re-incarnation : Muscle Stem Cells and Tissue Repair, Hematopoietic Stem Cells : Beyond Hematopoietic Reconstitution etc. Stem cells offer the promise of a new regenerative medicine in which the damaged adult cells can be replaced with new cells, which offers the hope of restoration of cellular function and relief from suffering associated with many disabling disorders. Beyond tissue repair cultured stem cells lines also offer unprecedented opportunities for drug screening of assays and as vehicles for gene therapy. Each potential use of stem cells promises revolutionary advances. The key-note address "Mesenchymal Stem Cells and their Differentiation" was delivered by the Chief Guest Prof. Paul Simmons, Peter MacCallum Research Institute, Australia. The symposium was well attended by over 150 scientists and students from all over India.

The 12th Annual Symposium on "Immunotherapeutics and Disease Management" was held at the All India Institute of Medical Sciences, New Delhi on November 28, 2005. Prof. Rolf M. Zinkernagel (Nobel Laureate), Institute of Experimental Immunology, University of Zurich, Switzerland, who was the Chief Guest also delivered the key-note address "Why do we not have a vaccine against TB or HIV as yet ?"

The symposium was co-sponsored by Immunology Foundation of India and was moderated by Prof. N.K. Mehra, Professor & Head of the Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi. Eminent scientists from around the world, deliberated on various topics related to the cellular basis of immune response, including immunotherapeutics, which has revolutionalised the treatment of many infectious diseases, inflammatory disorders, autoimmune disorders, HIV/AIDS and even cancer. The symposium was well attended by over 300 scientists and students from all over India.

The 13th Annual Symposium on "Impact of Lifestyle on Cardiovascular Health" was held at the All India Institute of Medical Sciences, New Delhi on March 20, 2007. Prof. Salim Yusuf, Professor of Medicine, McMaster University, Director, Population Health Research Institute, McMaster University, Hamilton Health Sciences, Chief Scientific Officer, Hamilton Health Sciences, Heart and Stroke Foundation Endowed Chair in Cardiovascular Research, Canada was the Chief Guest and Key-note Speaker. The topic of his key-note address was "The Global increase in Cardiovascular Diseases ………. Inevitable or Preventable ?"

This symposium unfolded the fact that the emerging social, demographic and epidemiological transition from the infectious diseases to the non-communicable diseases eg. Obesity, hypertension, diabetes mellitus, CAD, stroke, cancer, COPD etc. posed new challenges to the future health systems not only in India but also across the world and their prevention demanded a complex mix of interventions. It is in this context that the Foundation selected cardiovascular health as the theme for this symposium and had invited a galaxy of experts to share scientific information and wisdom on the topic. More than 200 scientists, students and academicians participated in the symposium. The symposium was held in collaboration with the departments of Endocrinology & Metabolism and Cardiology, All India Institute of Medical Sciences, New Delhi.

The 14 Annual symposium of Ranbaxy Science Foundation was held on January 14-15, 2008 at the National Institute of Immunology, New Delhi. The theme for symposium was "Emerging Frontiers in Management of Advanced Stage Cancers". The Symposium was co-sponsored by the Immunology Foundation.

The main objective of the symposium was to review the growing areas of research and development of new promising therapies for the better understanding and management of advanced stage cancers

The keynote address of the symposium tilted as, "Ramalingaswami Oration was delivered by Prof. David Baltimore, Nobel Laureate, President Emeritus, Robert Andrews Millikan Professor of Biology, California Institute of Technology, USA. The topic of the key-note address was "Inflammation : Roles of NF-kB and MicroRNAs"

A total of 27 scientific papers on a wide range of topics related to various aspects of the management of advanced cancers were presented during the two days symposium. A large number of eminent speakers not only from various reputed institutes of India like Tata Memorial Hospital, Mumbai, Prince Aly Khan Hospital, Mumbai, All India Institute of Medical Sciences, New Delhi, National Brain Research Centre, Manesar, Chittaranjan National Cancer Institute, Kolkata, National Centre for Cell Science, Pune Cancer Institute,Chennai, National Institute of Immunology, New Delhi but also from other countries like USA, UK, Canada, Germany, Netherlands and Denmark participated in the symposium.

The symposium was attended by over 250 doctors, scientists and medical students from all over India.

The XV Annual Symposium on “Hormonal Receptors and Women’s Health” was conducted on March 19, 2009 at the Jawaharlal Auditorium of Auditorium of All India Institute of Medical Sciences, New Delhi.

Prof. Gautam Chaudhuri, Distinguished Professor and Executive Chair of Obstetrics and Gynecology, David Geffen School of Medicine, University of California at Los Angeles (UCLA) USA was the Chief Guest and Key-note Speaker of the symposium. The topic of Prof. Choudhuri’s Key-note Address was “Hormone Therapy and Women’s Health : The Estrogoen Paradox”

The aim of this symposium was to identify health threats and define the future need of research in the areas of women’s health. Eminent scientists from across the world deliberated on the current scenario – regarding the role of hormones in women’s health in respect of problems related to reproduction, contraception, postmenopausal health, endometriosis, malignancies and other medical conditions like cardiovascular diseases, fractures etc.

The XVI Annual Symposium on “Emerging Frontiers in Immunogenomics of Infectious Diseases” was conducted on November 4, 2009 at the National Institute of Immunology, New Delhi.

Prof. Peter C. Doherty (Nobel Laureate), Laureate Professor, Department of Microbiology and Immunology, University of Melbourne, Australia was the Chief Guest and Key-note Speaker of the symposium. The topic of Prof. Doherty’s Key-note Address was “Inflammation and Immunity in Influenza”

The aim of this symposium was to review the dramatic progress being made in characterizing the human genome, state of our existing knowledge on genetic factors influencing susceptibility to some major infectious diseases and the potential of new molecular genetic approaches in this field including designing of vaccines as recent studies have indicated that host genetic factors are major determinants of susceptibility to infectious diseases in humans. Eminent scientists from India and abroad were deliberated on the emerging frontiers in the field of immunogenomics in respect of parasitic, bacterial, fungal and viral diseases and stressed the need for future research in these areas.

The XVII Annual Symposium on “New Frontiers in Drug Design, Discovery and Development” was conducted on February 11, 2011 at the National Institute of Immunology, New Delhi.

Dr. Hiroyuki Koike, Corporate Fellow-R&D Division, Daiichi Sankyo Co., Japan was the Chief Guest and Key-note Speaker of the symposium. The topic of Dr. Koike’s Key-note Address was “Innovations in Design and Discovery of New Drugs for Cardiovascular Disorders: Special Focus on the Drugs that Inhibit the Renin-Angiotensin System”.

The symposium focused on various topics in Drug Design, Discovery and Developemnt such as New approaches to Molecular modeling, Novel Peptido-mimetics, Approaches towards the development of chimeric DPPA/ACE inhibitor for treating metabolic syndrome, importance of chemical and biological space complementarity in drug discovery, improving R&D productivity through external innovation, new approaches to the development of antibacterial agents with special reference to quinolone, discovery of new anti-TB agents, discovery of novel anti-malarial drugs, integration between drug discovery and development, meeting the challenges of microbial resistances in infectious diseases, interface between traditional systems drugs and modern drug discovery and re-positioning of discovered drugs.

The symposium was attended by over 230 scientists and medical students across India.

Ranbaxy Science Foundation conducted its 18^th Annual Symposium on the topic “Ageing Gracefully” on February 27, 2012 at the Jawaharlal Nehru Auditorium, All India Institute of Medical Sciences, New Delhi in association with International Congress on Gerontology & Geriatric Medicine. The Co-Organizers of the symposium were All India Institute of Medical Sciences and University College of Medical Sciences, New Delhi.

Prof. Finbarr Martin, President, British Geriatrics Society, London was the Chief Guest and Key-note of the Symposium. The other three renowned international speakers in the symposium were Prof. Yasumichi Arai, Keio University School of Medicine, Japan, Prof. John Morley, Saint Louis University School of Medicine, USA and Prof. Peter Crome, Keele University, UK

The program of the symposium was well designed and experts from major research institutions were invited to deliver the lectures. The symposium addressed various topics like Human Longevity Research, Alzheimer’s Disease, Frailty - Joining the Geriatric Giants, Demographics of Ageing, Functional disability and its gender dimensions, Health Issues in Old Age, Vitamin D: skeletal and extra skeletal implications, Challenges of vascular diseases in ageing population, Civil society and policy formulation, National Program for Health Care of the Elderly etc.  This symposium was attended by as many as 300 delegates all over India.

The Foundation conducted its 19th Annual Symposium on the topic “Gains of Genomic Research in Biology and Medicine” on February 4, 2013 at the National Institute of Immunology, New Delhi under the convenership of Prof. N.K. Mehra, Head, Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi. The symposium was co-sponsored by Immunology Foundation.

Prof. Dhavendra Kumar, Consultant in Clinical Genetics, Institute of Molecular and Experimental Medicine, University Hospital of Wales, Cardiff, UK was the Chief Guest and Key-note speaker at the symposium. A special lecture on “Generic Drugs to Genomic Medicines” was delivered by Prof. Samir K. Brahmachari, Director General, Council of Scientific and Industrial Research, Government of India. The other prominent speakers were Prof. I.C. Verma, Sir Ganga Ram Hospital, Dr. Bert de Vries from University of Nijmegan, Netherlands, Dr. GPS Raghava, IMTECH, Chandigarh, Dr. Rajiv Sarin, The Advanced Centre for Treatment, Research and Education in Cancer, Mumbai Dr. Seyed Hasnain, Indian Institute of Technology, New Delhi etc. The symposium addressed various issues like Genome to Genetic medicine : Opportunities and Challenges, Genetic Council in the Genomic Era, Genetic and Genomic Tools in Clinical Diagnosis, Genomic Architecture of HIV Infection, in silico Design of Subunit Vaccines, Genetics of Breast Cancer in Indian Population, Genetic Variations and its Implications in Health and Diseases etc.

This symposium received a good response from the scientific community including young researchers, students and it was attended by as many as 270 delegates all over India.

The 20th Annual Symposium of the Foundation on the topic “Regenerative Medicine – Current and Future Perspectives” was held on March 22, 2014 at the National Institute of Immunology, New Delhi. The symposium was jointly organized with Institute of Liver and Biliary Sciences (ILBS), New Delhi. The Chief Guest, Dr. R. Chidambaram, Principal Scientific Adviser to the Government of India delivered the inaugural address followed by the key note address by Prof. Pierre Alain Clavien. Eminent scientists from India and abroad participated in the symposium and deliberated on the recent advances in regenerative medicine and stem cell therapy and its recent applications in various disease areas such as kidney disorders, type II diabetes mellitus, neuronal disorder, ocular disorders, liver injury, cardiac disorders etc.
The symposium was attended by over 230 delegates from all over India.